Disclaimer: All these posts are generated with the help of AI systems, and there could be mistakes
There are, however, simple economics of drug development processes that make it so BPC-157 likely will never go through the full process of drug approval because of financial incentives
Enhanced Collagen Fiber Organization: Histological analysis of BPC-157-treated tendons shows parallel, well-aligned collagen fibers compared to the disorganized scar matrix found in untreated tissue
Its regenerative properties make it a powerful tool in promoting tissue repair
confirming MOTS-c as a promising mitochondrial-derived peptide with anti-inflammatory and metabolic effects, MOTS-c has been shown to significantly reduce pro-inflammatory markers, improve glucose utilization, and act on fat tissue in ways that make it more directly metabolic than NAD+ in this context
After this, its sterility cannot be guaranteed